NCT04891718 2022-07-08
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
3 trialsNCT04223648 2021-11-22
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma
Yale University
Phase EARLY_PHASE1 Withdrawn
NCT04285749 2020-07-27
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Withdrawn